KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Share-based Compensation (2017 - 2025)

Johnson & Johnson (JNJ) has disclosed Share-based Compensation for 17 consecutive years, with $309.0 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation rose 29.83% to $309.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 15.14% year-over-year, with the annual reading at $1.4 billion for FY2025, 15.14% up from the prior year.
  • Share-based Compensation hit $309.0 million in Q4 2025 for Johnson & Johnson, down from $347.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $410.0 million in Q2 2025 to a low of $160.0 million in Q1 2021.
  • Historically, Share-based Compensation has averaged $292.7 million across 5 years, with a median of $299.0 million in 2023.
  • Biggest five-year swings in Share-based Compensation: decreased 18.35% in 2023 and later skyrocketed 33.71% in 2024.
  • Year by year, Share-based Compensation stood at $259.0 million in 2021, then grew by 7.34% to $278.0 million in 2022, then plummeted by 35.97% to $178.0 million in 2023, then soared by 33.71% to $238.0 million in 2024, then grew by 29.83% to $309.0 million in 2025.
  • Business Quant data shows Share-based Compensation for JNJ at $309.0 million in Q4 2025, $347.0 million in Q3 2025, and $410.0 million in Q2 2025.